Clinical trial

A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread

NCT02057133

Study summary

ClinicalTrials.gov

A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread

Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: PHASE1

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

12 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention LY2835219 Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Letrozole Normalized identity: letrozole View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Anastrozole Normalized identity: anastrozole View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Tamoxifen Normalized identity: tamoxifen View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Exemestane Normalized identity: exemestane View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Everolimus Normalized identity: everolimus View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Trastuzumab Normalized identity: trastuzumab View linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention LY3023414 Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Fulvestrant Normalized identity: fulvestrant View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Pertuzumab Normalized identity: pertuzumab View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Loperamide Normalized identity: loperamide View linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Endocrine therapy Find medicine records · Find other trials using this name

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2014-03-10

PhasePHASE1

Conditions

Breast Neoplasmsunresolved

Interventions

LY2835219DRUG

LetrozoleDRUG · verified · RxNorm: letrozole

AnastrozoleDRUG · verified · RxNorm: anastrozole

TamoxifenDRUG · verified · RxNorm: tamoxifen

ExemestaneDRUG · verified · RxNorm: exemestane

EverolimusDRUG · verified · RxNorm: everolimus

TrastuzumabDRUG · verified · RxNorm: trastuzumab

LY3023414DRUG

FulvestrantDRUG · verified · RxNorm: fulvestrant

PertuzumabDRUG · verified · RxNorm: pertuzumab

LoperamideDRUG · verified · RxNorm: loperamide

Endocrine therapyDRUG

Sponsors & collaborators

Eli Lilly and Companylead sponsor

Mapped research locations

NashvilleTennessee, United States3 New YorkNew York, United States2 BostonMassachusetts, United States1 San AntonioTexas, United States1 PittsburghPennsylvania, United States1 PortlandOregon, United States1 RochesterMinnesota, United States1 Chapel HillNorth Carolina, United States1 La JollaCalifornia, United States1 RogersArkansas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02057133 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.